Zhengyu Yu

State Key Laboratory Of Biotherapy And Cancer Center
Chengdu, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

YMN-V115: a novel humanized BCMA/GPRC5D/CD3 trispecific antibody in relapsed/refractory multiple myeloma.

YMN-V115: a novel humanized BCMA/GPRC5D/CD3 trispecific antibody in relapsed/refractory multiple myeloma.

Journal: Journal for immunotherapy of cancer
Published: February 04, 2026

Multiple myeloma derived sulfur dioxide drives CAR-T cell exhaustion by inducing mitochondrial dysfunction.

Multiple myeloma derived sulfur dioxide drives CAR-T cell exhaustion by inducing mitochondrial dysfunction.

Journal: Redox biology
Published: December 06, 2025

A novel CLDN6 nanobody-based bispecific T-cell engager delivered by self-amplifying RNA platform exhibits potent antitumor efficacy.

A novel CLDN6 nanobody-based bispecific T-cell engager delivered by self-amplifying RNA platform exhibits potent antitumor efficacy.

Journal: Journal of nanobiotechnology
Published: November 26, 2025

Evidence for the Monitoring of Minimal Residual Disease Dynamics to Guide Clinical Practice in Patients with Multiple Myeloma.

Evidence for the Monitoring of Minimal Residual Disease Dynamics to Guide Clinical Practice in Patients with Multiple Myeloma.

Journal: Targeted oncology
Published: November 18, 2025

Efficacy and Safety of Immune Checkpoint Inhibitors in the Treatment of Hematologic Malignancies: An Umbrella Review of Systematic Reviews and Meta-Analyses.

Efficacy and Safety of Immune Checkpoint Inhibitors in the Treatment of Hematologic Malignancies: An Umbrella Review of Systematic Reviews and Meta-Analyses.

Journal: Cancer medicine
Published: November 10, 2025

Prolonged duration of pharmacological thromboprophylaxis following oncologic surgery: A systematic review and meta-analysis of RCTs.

Prolonged duration of pharmacological thromboprophylaxis following oncologic surgery: A systematic review and meta-analysis of RCTs.

Journal: Thrombosis research
Published: June 20, 2025

Efficacy and safety of chimeric antigen receptor T-cell in the treatment of hematologic malignancy: an umbrella review of systematic review and meta-analysis.

Efficacy and safety of chimeric antigen receptor T-cell in the treatment of hematologic malignancy: an umbrella review of systematic review and meta-analysis.

Journal: Frontiers in immunology
Published: April 09, 2025

Global, regional, and national burden of glucose-6-phosphate dehydrogenase (G6PD) deficiency from 1990 to 2021: a systematic analysis of the global burden of disease study 2021.

Global, regional, and national burden of glucose-6-phosphate dehydrogenase (G6PD) deficiency from 1990 to 2021: a systematic analysis of the global burden of disease study 2021.

Journal: Frontiers in genetics
Published: March 20, 2025

Dietary Flavonoid Intake and Anemia Risk in Children and Adolescents: Insights from National Health and Nutrition Examination Survey.

Dietary Flavonoid Intake and Anemia Risk in Children and Adolescents: Insights from National Health and Nutrition Examination Survey.

Journal: Antioxidants (Basel, Switzerland)
Published: February 06, 2025

Vascular smooth muscle cell-derived SO2 sulphenylated interferon regulatory factor 1 to inhibit VSMC senescence.

Vascular smooth muscle cell-derived SO2 sulphenylated interferon regulatory factor 1 to inhibit VSMC senescence.

Journal: Frontiers in pharmacology
Published: October 25, 2024

Innovative strategies for improving CAR-T cell therapy: A nanomedicine perspective.

Innovative strategies for improving CAR-T cell therapy: A nanomedicine perspective.

Journal: Chinese medical journal
Published: August 14, 2024

A nanobody-based tri-specific NK cell engager targeting CD5 triggers antitumor immunity.

A nanobody-based tri-specific NK cell engager targeting CD5 triggers antitumor immunity.

Journal: Cell reports. Medicine
Published: August 05, 2024
Showing 1-12 of 23

Last Updated: 09/26/2026